Gilead Sciences (GILD) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Gilead Sciences (GILD) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: November 7, 2024 (12:50)

Sector: Healthcare

The share price of Gilead Sciences, Inc. (GILD) now

Latest session on the 6th of November for
Gilead Sciences, Inc. is positive
Trading Volume: 8819291
Open: 91 /  High: 91.98 /  Low: 90.5
What analysts predict: $87.58
52-week High/Low: $90.71 / $60.75
50-Day Moving Average: $84.01 — support level today
200-Day Moving Average: $74.19 — support level today

Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2024, 2025, 2026. How much will one Gilead Sciences share be worth in 2024 - 2026?

When should I take profit in Gilead Sciences stock? When should I record a loss on Gilead Sciences stock? What are analysts' forecasts for Gilead Sciences stock? What is the future of Gilead Sciences stock? We forecast Gilead Sciences stock performance using neural networks based on historical data on Gilead Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Gilead Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Gilead Sciences shares. This happens once a day.


Historical and forecast chart of Gilead Sciences stock

The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Gilead Sciences stock price can be found in the table below.

Long-term forecasts by years.

Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.

Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.

Official site of the company

Trending Themes in the Healthcare Sector

Gilead Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 09 92.56 92.10 92.82 0.78
Nov 10 92.34 92.00 92.54 0.59
Nov 11 91.63 91.12 92.02 0.99
Nov 12 91.05 90.38 91.52 1.27
Nov 13 91.58 90.89 91.84 1.04
Nov 14 91.70 91.29 92.30 1.12
Nov 15 92.08 91.68 92.48 0.87
Nov 16 91.93 91.46 92.40 1.03
Nov 17 92.37 91.72 93.02 1.42
Nov 18 92.15 91.70 92.58 0.95
Nov 19 91.59 91.24 91.93 0.76
Nov 20 91.66 91.02 92.13 1.23
Nov 21 91.61 91.27 91.83 0.61
Nov 22 92.15 91.73 92.57 0.91
Nov 23 92.80 92.15 93.34 1.29
Nov 24 92.44 91.92 93.05 1.24
Nov 25 92.25 91.84 92.99 1.25
Nov 26 91.84 91.13 92.19 1.17
Nov 27 90.97 90.68 91.36 0.75
Nov 28 90.35 89.80 91.03 1.37
Nov 29 89.93 89.34 90.65 1.46
Nov 30 89.84 89.39 90.20 0.90
Dec 01 89.50 89.19 89.87 0.76
Dec 02 89.33 88.77 89.57 0.90
Dec 03 90.06 89.68 90.38 0.77
Dec 04 90.56 90.01 90.75 0.83
Dec 05 90.57 90.38 91.11 0.80
Dec 06 90.12 89.57 90.80 1.37
Dec 07 89.34 88.88 89.83 1.07
Dec 08 89.10 88.86 89.36 0.56

Gilead Sciences Daily Price Targets


Gilead Sciences Stock Forecast 11-09-2024.

Forecast target price for 11-09-2024: $92.56.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 0.778%.
Pessimistic target level: 92.10
Optimistic target level: 92.82

Gilead Sciences Stock Forecast 11-10-2024.

Forecast target price for 11-10-2024: $92.34.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.589%.
Pessimistic target level: 92.00
Optimistic target level: 92.54

Gilead Sciences Stock Forecast 11-11-2024.

Forecast target price for 11-11-2024: $91.63.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.976%.
Pessimistic target level: 91.12
Optimistic target level: 92.02

Gilead Sciences Stock Forecast 11-12-2024.

Forecast target price for 11-12-2024: $91.05.
Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 1.254%.
Pessimistic target level: 90.38
Optimistic target level: 91.52

Gilead Sciences Stock Forecast 11-13-2024.

Forecast target price for 11-13-2024: $91.58.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.027%.
Pessimistic target level: 90.89
Optimistic target level: 91.84

Gilead Sciences Stock Forecast 11-14-2024.

Forecast target price for 11-14-2024: $91.70.
Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.103%.
Pessimistic target level: 91.29
Optimistic target level: 92.30

GILD (GILD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Dec. 92.43 91.14 95.53 4.60

Gilead Sciences forecast for this year


Gilead Sciences Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $92.4304. Pessimistic: $91.14. Optimistic: $95.53



Gilead Sciences (GILD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 94.56 91.72 96.68 5.13
Feb 92.43 91.00 93.91 3.10
Mar 92.66 91.55 96.04 4.68
Apr 91.87 88.79 94.63 6.17
May 89.62 86.48 90.79 4.74
Jun 93.92 91.86 97.26 5.55
Jul 95.14 92.19 98.95 6.83
Aug 94.76 92.30 96.99 4.84
Sep 99.26 98.07 101.10 2.99
Oct 97.73 94.11 99.19 5.12
Nov 95.77 93.81 96.87 3.16
Dec 98.07 96.89 101.45 4.50

Gilead Sciences (GILD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 99.30 95.72 103.12 7.17
Feb 104.11 102.92 105.15 2.13
Mar 101.77 99.94 103.86 3.77
Apr 101.11 98.23 104.09 5.63
May 100.25 98.90 104.01 4.92
Jun 98.64 96.23 101.36 5.06
Jul 96.47 93.34 97.87 4.63
Aug 98.55 95.20 101.65 6.35
Sep 100.47 98.86 102.18 3.24
Oct 102.03 99.17 104.73 5.31
Nov 107.13 105.20 111.20 5.39
Dec 110.61 106.30 115.04 7.60

Gilead Sciences information and performance

Gilead Sciences Address

333 LAKESIDE DR, FOSTER CITY, CA, US

Market Capitalization: 112 322 994 000 $

Market capitalization of the Gilead Sciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GILD shares in the company outstanding by the market price of one share.

EBITDA: 13 462 000 000 $

EBITDA of Gilead Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: 110.02

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.526

Price/earnings to growth

DPS: 3.04

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0343

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 0.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.554
Quarterly Revenue Growth YOY: 0.054
Trailing PE: 110.02

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 12.33

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.78

Enterprise Value (EV) /Revenue

EV To EBITDA: 25.22

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1244990000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Gilead Sciences (GILD) stock dividend

Gilead Sciences last paid dividends on 09/13/2024. The next scheduled payment will be on 09/27/2024. The amount of dividends is $3.04 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.